Navigation Links
InteRNA Technologies and VU University Medical Center to Develop microRNA-Based Diagnostics and Therapeutics for Cancer
Date:10/30/2008

chnologies B.V. actively explores and exploits opportunities to translate its unique collection of miRNAs and miRNA discovery and validation technologies into successful diagnostic, prognostic and therapeutic applications. The company's primary focus is to unravel the role of its proprietary miRNAs in cancer.

InteRNA Technologies was incorporated in 2006 by Aglaia Oncology Fund and has established close relationships with the research groups of its founders Edwin Cuppen, PhD, and Eugene Berezikov, PhD, of the Hubrecht Institute (Utrecht, the Netherlands), leading scientific groups in the field of miRNA research.

See for more information http://www.interna-technologies.com.

About VUmc

VU University Medical Center's core business consists of patient care, scientific research, and education. Its pivotal points in care and research are cancer and immunity, the brain, movement, vital functions and extramural care. Each year 38,000 patients are admitted (including one-day admissions), well over 300,000 patients visit the Outpatients department and 40,000 arrive at the Accident and Emergency department. Approximately 2,000 medical students are in training here. Each year, VU University Medical Center produces around 2,000 scientific publications and reports based on the scientific research carried out here. This includes the results of thesis research projects being carried out by 100 PhD students.


'/>"/>
SOURCE InteRNA Technologies B.V.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Intellect Neurosciences, Inc. to Present Data on Alzheimers Vaccine at 13th International Congress of Immunology Conference
2. Paper in International Journal of Oncology Reports Alfacells ONCONASE(R) Suppresses Intracellular Oxidative Stress
3. Ozarelix Phase 2 Data Presented at 29th Congress of the Societe Internationale dUrologie
4. Anadys Pharmaceuticals Presents Preclinical Results on ANA598, a Non-Nucleoside Inhibitor of the NS5B Polymerase, at the 14th International Symposium on Hepatitis C Virus and Related Viruses
5. International Expert Group Initiates Largest Multi-center Phase III Trial to Evaluate NeuroAid(TM) in Stroke Recovery
6. Surface Logix Presents Positive Phase 1 Repeat-Dose Trial Data on SLx-4090 at The 16th International Symposium on Drugs Affecting Lipid Metabolism
7. Preclinical Data on Lead MEK Inhibitor, RDEA119, to be Presented at the 2007 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics
8. Tumor Growth Inhibition and Pharmacokinetic Profile of NKTR-102 (PEG-Irinotecan) in Multiple Solid Tumors To Be Presented at Upcoming AACR-NCI-EORTC International Conference
9. Preimplantation Genetic Diagnosis International Society Refutes American Society of Reproductive Medicine Opinion - States Preimplantation Genetic Screening is Beneficial When Performed in Experienced Centers
10. Survival Data for Avicenas Amyotrophic Lateral Sclerosis Drug Candidate, AL-02, to be Presented at 18th International Symposium on ALS/MND
11. CEL-SCI CEO to Present at the International Society for Pharmaceutical Engineering 2007 Chesapeake BioShowcase
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/29/2014)... -- Research and Markets has announced the ... 2014-2017" report to their offering. ... reimbursement for medical expenses, the Chinese orthopedic instrument market ... a CAGR of 19.2% during 2009-2013. Trauma products, spine ... orthopedic instruments in China , of ...
(Date:8/29/2014)... , August 29, 2014 ... Oil Market by Extraction type (SFE, Cold Pressed, ... Personal Care, Pharmaceutical, Food Supplements, Fragrance, & Others) - ... MarketsandMarkets, defines and segments the Amaranth Seed Oil ... market size in terms of value. The Amaranth ...
(Date:8/29/2014)... , Aug. 29, 2014  United Therapeutics Corporation (NASDAQ: ... District Court for the District of New ... the company,s case against Sandoz, Inc. regarding United Therapeutics, ... Sheridan ruled that U.S. Patent No. 6,765,117 is ... Sandoz from marketing its generic product until the expiration ...
Breaking Medicine Technology:China Orthopedic Instrument Industry Report, 2014-2017 2Amaranth Seed Oil Market worth $700.6 Million by 2019 2Amaranth Seed Oil Market worth $700.6 Million by 2019 3Amaranth Seed Oil Market worth $700.6 Million by 2019 4District Court Decision Received In Remodulin Patent Case 2
... recognized for identifying healthy solutions that empower men and women ... natural supplement which includes an ingredient that clinical tests revealed ... by 98%. Men who take Mdrive daily report ... focus. Mdrive - A synergistic blend ...
... ReportsnReports - U.S. Rehabilitation Technology Market ... This research service covers the following market ... electrotherapy - muscle Stimulators, clinical electrotherapy - ultrasound, ... diathermy, continuous passive motion (CPM) machines, clinical treatment ...
Cached Medicine Technology:DreamBrands New Formula Helps Men Feel Younger and Stronger While Naturally Raising Low-T Without Prescription Drugs 2ReportsnReports Adds Market Research Report on U.S. Rehabilitation Technology Market in its Store 2ReportsnReports Adds Market Research Report on U.S. Rehabilitation Technology Market in its Store 3ReportsnReports Adds Market Research Report on U.S. Rehabilitation Technology Market in its Store 4ReportsnReports Adds Market Research Report on U.S. Rehabilitation Technology Market in its Store 5
(Date:8/29/2014)... York, New York (PRWEB) August 29, 2014 ... from cardiac arrest following a series of dialysis treatments ... that alleges her death was the result of Fresenius ... LLP reports. The family’s lawsuit, which was file d ... claims that the use of the products resulted in ...
(Date:8/29/2014)... AURORA, Colo. (Sept. 2, 2014) A team of ... has reported the breakthrough discovery of a process to ... patients. These findings could have implications that extend beyond ... and autoimmune diseases., In an article published ... the Charles C. Gates Center for Regenerative Medicine and ...
(Date:8/29/2014)... IL (PRWEB) August 29, 2014 ... poised to begin accepting applications next month for ... are transitioning into accepting marijuana as a legalized ... and dispensaries will be permitted to operate in ... communities will be best suited to handle legal ...
(Date:8/29/2014)... LiveOps, Inc., the global leader in ... that LiveOps has been selected as a call center ... Strength Telethon for the third year in a row. ... to support MDA’s mission to help children and adults ... muscle disease. This year’s program includes performances by Bret ...
(Date:8/29/2014)... (PRWEB) August 29, 2014 Thirteen ... the prestigious Great 100 Nurses in North ... recognizes nursing excellence and provides scholarships to nursing students ... recognized from Novant Health Presbyterian Medical Center ... Lisa Kelley, Nora King, Lissa Ready, Amber Segerlin, Carmen ...
Breaking Medicine News(10 mins):Health News:GranuFlo Lawsuit News: Family Alleges Woman’s Death Following Dialysis Was Caused by GranuFlo and NaturaLyte, Bernstein Liebhard LLP Reports 2Health News:GranuFlo Lawsuit News: Family Alleges Woman’s Death Following Dialysis Was Caused by GranuFlo and NaturaLyte, Bernstein Liebhard LLP Reports 3Health News:GranuFlo Lawsuit News: Family Alleges Woman’s Death Following Dialysis Was Caused by GranuFlo and NaturaLyte, Bernstein Liebhard LLP Reports 4Health News:CU scientists' discovery could lead to new cancer treatment 2Health News:Medical Marijuana Approaches Legalization in Chicago 2Health News:LiveOps Supports Muscular Dystrophy Association Show of Strength Telethon 2Health News:LiveOps Supports Muscular Dystrophy Association Show of Strength Telethon 3Health News:LiveOps Supports Muscular Dystrophy Association Show of Strength Telethon 4Health News:Great 100 Honors 13 Novant Health Nurses 2
... Feb. 3 President Obama,s budget proposals to reduce ... harm fundraising for nonprofit hospitals by thwarting giving by wealthy ... and underinsured, according to the Association for Healthcare Philanthropy whose ... systems across the U.S. and Canada . , "Despite ...
... MATEO, Calif. , Feb. 3 SCAN Health Plan ... Northern California exceeded company projections with more than 3,100 ... Eligible individuals may continue to join SCAN until March 31 ... California and Arizona , SCAN is now available to ...
... inflammatory chemokine were significantly elevated in patients with ... research conducted by scientists at the Jefferson Pancreatic, ... data at the 5th Annual Academic Surgical Congress, ... that obesity is correlated with inflammation. Similarly, studies ...
... European Association for Predictive, Preventive and Personalised Medicine have ... Journal . Creating a reliable scientific platform for ... in biomedicine and laboratory medicine, the EPMA Journal ... of predictive, preventive and personalised medicine. The ...
... , ... Conn. , Feb. 3 The National Organization for Rare ... DETECTIVES , will serve as media and program partners for Rare Disease ... U.S. observance of Rare Disease Day, an event designed to call attention ...
... - People have typically viewed the benefits that accrue with ... A new paper in the February 1st issue of ... internal rewards as well. Dr. Martinez and colleagues found ... the density of dopamine D2/D3 receptors in the striatum, a ...
Cached Medicine News:Health News:Obama's Budget Proposals Will Thwart Charitable Giving to Keep Nonprofit Hospitals Operating, Association for Healthcare Philanthropy Says 2Health News:Obama's Budget Proposals Will Thwart Charitable Giving to Keep Nonprofit Hospitals Operating, Association for Healthcare Philanthropy Says 3Health News:SCAN Health Plan's Northern California Launch Embraced by Local Seniors 2Health News:Springer publishes new journal in predictive, preventive and personalized medicine 2Health News:Discovery Health and National Organization for Rare Disorders Partner for Second Annual Rare Disease Day With the Premiere of the Special DISEASE DETECTIVES 2Health News:Discovery Health and National Organization for Rare Disorders Partner for Second Annual Rare Disease Day With the Premiere of the Special DISEASE DETECTIVES 3Health News:Discovery Health and National Organization for Rare Disorders Partner for Second Annual Rare Disease Day With the Premiere of the Special DISEASE DETECTIVES 4Health News:Discovery Health and National Organization for Rare Disorders Partner for Second Annual Rare Disease Day With the Premiere of the Special DISEASE DETECTIVES 5Health News:Discovery Health and National Organization for Rare Disorders Partner for Second Annual Rare Disease Day With the Premiere of the Special DISEASE DETECTIVES 6Health News:Brain dopamine receptor density correlates with social status 2
... Activa Parkinson's Control Therapy uses electrical ... some of the most disabling motor ... Control Therapy is a safe and ... Parkinson's patients. Activa Therapy controls rigidity, ...
... It features over 600 TV lines of ... has four color temperature selections, scanning size selection ... control allows the user to easily set up ... settings for brightness, chroma, phase, contrast, volume and ...
Craniosorb Absorbable Fixation System (AFS) is uniquely designed to offer simple and reproducible fixation of the cranial flap and allow for complete absorption of the plating system over time....
PoleStar N-10 is a compact MRI unit that does not require a specially constructed surgery suite. The magnetic field is confined to the volume between the magnet poles and it's immediate neighborhood....
Medicine Products: